Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study
Surgery Today · 2025-04 · 55 (4) · 510-517
DOI: 10.1007/s00595-024-02930-x ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Surgery Today, online erschienen am 27.08.2024. Verfasst von Norifumi Iseda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatectomy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: In recent years, new systemic therapies have been developed for hepatocellular carcinoma (HCC). The aim of this study was to evaluate the prognosis of patients with unresectable HCC treated with R0 hepatectomy after systemic therapy. METHODS: Data from 27 patients who underwent hepatectomy for HCC after systemic therapy at six facilities were analyzed retrospectively. Cancer-specific survival (CSS) and recurrence-free survival (RFS) after hepatectomy were investigated using Kaplan-Meier curves. We examined the prognostic value of the oncological criteria of resectability for HCC reported by the Japanese Expert Consensus 2023. RESULTS: R0 resection was performed in 24 of the 27 patients. Using the Response Evaluation Criteria in Solid Tumors, 0 patient had a complete response, 16 had a partial response, 6 had stable disease, and 2 had progressive disease. Median CSS was not evaluated, but the median RFS was 17.8 months. Patients with resectable and borderline resectable (BR) 1 cancers had a better prognosis than those with BR2 cancers. The group whose oncological criteria were improved by systemic therapy had a lower recurrence rate than the group whose oncological criteria were maintained, but no difference was observed in CSS. CONCLUSIONS: The findings of this study suggest that hepatectomy after systemic therapy may improve the prognosis of HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. itoh.shinji.453@m.kyushu-u.ac.jp.
- Department of Surgery, Oita Prefectural Hospital, Oita, 870-8511, Japan.
- Department of Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan.
- Department of Surgery, Fukuoka City Hospital, Fukuoka, 812-0046, Japan.
- Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, 810-0001, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Iseda, N., Itoh, S., Toshima, T., Yoshiya, S., Bekki, Y., Tsutsui, Y., Toshida, K., Inokuchi, S., Utsunomiya, T., Tomino, T., Sugimachi, K., Morita, K., Ninomiya, M., Harada, N., Minagawa, R., & Yoshizumi, T. (2025). Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study. Surgery Today, 55(4), 510-517. https://doi.org/10.1007/s00595-024-02930-x
Vancouver
Iseda N, Itoh S, Toshima T, Yoshiya S, Bekki Y, Tsutsui Y, et al. Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study. Surgery Today. 2025;55(4):510-517. doi:10.1007/s00595-024-02930-x
BibTeX
@article{Iseda2025,
author = {Iseda, Norifumi and Itoh, Shinji and Toshima, Takeo and Yoshiya, Shohei and Bekki, Yuki and Tsutsui, Yuriko and Toshida, Katsuya and Inokuchi, Shoichi and Utsunomiya, Toru and Tomino, Takahiro and Sugimachi, Keishi and Morita, Kazutoyo and Ninomiya, Mizuki and Harada, Noboru and Minagawa, Ryosuke and Yoshizumi, Tomoharu},
title = {Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study},
journal = {Surgery Today},
year = {2025},
volume = {55},
number = {4},
pages = {510--517},
doi = {10.1007/s00595-024-02930-x}
}
EUVIMED